Bio-Rad Laboratories

Bio-Rad Laboratories

Yahoo Finance • 10 days ago

Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption

Company Logo Biologics, biosimilars and personalized therapies are fueling CDMO outsourcing, while AI, automation and single-use systems enable scalable, compliant protein production. Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Recombinan... Full story

Yahoo Finance • 13 days ago

Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership

Company Logo Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magneti... Full story

Yahoo Finance • 17 days ago

Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius

Company Logo Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion. Dublin, Sept. 24, 2026 (GLOBE NEWSWI... Full story

Yahoo Finance • 18 days ago

Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share

Company Logo Personalized medicine and chronic disease care are driving demand for TDM, with opportunities in consumables, automation, point-of-care devices, AI software and pharmacogenomics. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "T... Full story

Yahoo Finance • 25 days ago

Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum

HERCULES, Calif., September 16, 2026--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K.... Full story

Yahoo Finance • last month

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

Company Logo The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%;... Full story

Yahoo Finance • last month

Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference

HERCULES, Calif., August 31, 2026--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. Lak... Full story

Yahoo Finance • 2 months ago

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExec... Full story

Yahoo Finance • 2 months ago

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035"... Full story

Yahoo Finance • 2 months ago

Bio-Rad forecasts 2026 currency-neutral revenue growth of (-3%) to +0.5% while targeting $30M-$35M net cost savings by end of 2027

Earnings Call Insights: Bio-Rad Laboratories (BIO) Q2 2026 MANAGEMENT VIEW * "Total company revenue in the second quarter was approximately $651 million, essentially flat as reported and down 1.9% on a currency-neutral basis compared w... Full story

Yahoo Finance • 2 months ago

SR Inc Net Zero Consortium for Buyers: Seven-Buyer Aggregation for 180 MW of Millers Branch Solar Now Online

BOSTON, Aug. 4, 2026 /PRNewswire/ -- The 180 MW Phase II portion of the Millers Branch Solar Facility in Haskell County, Texas has achieved commercial operation. The capacity was contracted through Sustainability Roundtable, Inc's Net Zero... Full story

Yahoo Finance • 3 months ago

Longleaf Partners Fund exits BIO

* Longleaf Partners Fund underperformed with a return of 3.87% in Q2, as compared to the S&P 500's 15.20% gain and the Russell 1000 Value Index's 13.87% advance. * The fund initiated one new position in a healthcare company during Q2 2... Full story

Yahoo Finance • 3 months ago

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Hematologic Malignancies Testing Market size & share revenue was valued at approximat... Full story

Yahoo Finance • 4 months ago

Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at app... Full story

Yahoo Finance • 4 months ago

Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas

Global supply chain leaders recognized for delivering bold innovation, agility, and measurable impact LAS VEGAS, June 04, 2026--(BUSINESS WIRE)--Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain planning and orchestration, t... Full story

Yahoo Finance • 5 months ago

Stocks Pressured by a Rebound in Crude Prices and Bond Yields

The S&P 500 Index ($SPX) (SPY) today is down -0.20%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.04%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.57%.  June E-mini S&P futures (ESM26) are down -0.28%, and June E-mini Na... Full story

Yahoo Finance • 5 months ago

Stocks Mixed as Crude Oil Prices and Bond Yields Fall

The S&P 500 Index ($SPX) (SPY) today is up +0.07%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.25%.  June E-mini S&P futures (ESM26) are up +0.10%, and June E-mini Nasdaq f... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: Regeneron, Dominion, Mobileye, Viking and more

Check out the companies making the biggest moves in midday trading: Dominion Energy — Shares popped more than 9% after NextEra Energy announced a deal to acquire the company in an all-stock transaction. NextEra said the combination of the... Full story

Yahoo Finance • 5 months ago

Sector Update: Healthcare Stocks Decline Pre-Bell Monday

Healthcare stocks were declining pre-bell Monday, with the State Street Health Care Select Sector SP PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves premarket: Regeneron, Dominion Energy, Macy's & more

Check out the companies making the biggest moves premarket: Regeneron Pharmaceuticals — The drugmaker fell more than 11% after its treatment for a skin cancer missed goals in a late-stage trial. Macy's — The department store shares jumped... Full story